Skip to content

ReliOn Prime Blood Glucose Monitoring SystemRecalls & reported problems across all models

Wal-Mart Stores, Inc. · 2 models in the FDA device registry

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
20
Deaths reported
0
Injuries reported
9
Recalls
0

We found 2 models of ReliOn Prime Blood Glucose Monitoring System by Wal-Mart Stores, Inc. in the FDA's device registry (GUDID). Together they are named in 20 adverse event reports in the FDA's MAUDE database, received between Dec 7, 2016 and Jul 27, 2022 — classified as 9 injuries, 11 malfunctions.

The most frequently reported specific device problem is “High Readings” (7 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Most reported ReliOn Prime Blood Glucose Monitoring System problems

Device problems

  • High Readings7
  • Low Test Results7
  • Device Displays Incorrect Message2
  • Incorrect Or Inadequate Test Results2
  • Missing Test Results2
  • Incorrect Measurement1
  • Low Readings1

Patient problems

  • No Known Impact Or Consequence To Patient12
  • Hyperglycemia4
  • Hypoglycemia4
  • Seizures1

ReliOn Prime Blood Glucose Monitoring System models

2 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent ReliOn Prime Blood Glucose Monitoring System adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Wal-Mart Stores, Inc. products

All Wal-Mart Stores, Inc. devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page